SOAT1 and diabetes mellitus: JAK/STAT inhibitors and mouse models with genetic deletion or overexpression of JAK/STAT pathway proteins have not been used to evaluate the therapeutic potential of modulating this pathway to alleviate DM-induced lung fibrosis.